Hawkins, Inc.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: US4202611095
USD
142.57
-0.43 (-0.3%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Hawkins, Inc. stock-summary
stock-summary
Hawkins, Inc.
Specialty Chemicals
Hawkins, Inc. distributes, blends and manufactures chemicals and specialty ingredients for its customers in a range of industries. The Company conducts its business in three segments: Industrial, Water Treatment, and Health and Nutrition. Its Industrial segment is engaged in providing industrial chemicals, products and services to various industries, such as agriculture, chemical processing, electronics and energy. Its Water Treatment segment is engaged in providing chemicals, equipment and solutions for potable water, municipal and industrial wastewater, industrial process water and non-residential swimming pool water. The Health and Nutrition segment is engaged in providing ingredient distribution, processing and formulation solutions to manufacturers of nutraceutical, functional food and beverage, personal care, dietary supplement and other nutritional food, and health and wellness products.
Company Coordinates stock-summary
Company Details
2381 Rosegate , ROSEVILLE MN : 55113-2625
stock-summary
Tel: 1 612 3316910
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 77 Schemes (42.94%)

Foreign Institutions

Held by 108 Foreign Institutions (6.3%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. John McKeon
Independent Chairman of the Board
Mr. Patrick Hawkins
President, Chief Executive Officer, Director
Mr. James Thompson
Independent Vice Chairman of the Board
Mr. Daniel Stauber
Director
Mr. James Faulconbridge
Independent Director
Ms. Mary Schumacher
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
293 Million
(Quarterly Results - Jun 2025)
Net Profit:
29 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 3,665 Million (Small Cap)

stock-summary
P/E

33.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

103.84%

stock-summary
Debt Equity

0.59

stock-summary
Return on Equity

17.33%

stock-summary
Price to Book

7.56